UNSPSC 85814715: Introduction of oxazolidinones into female reproductive, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of oxazolidinones into female reproductive, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0P328

UNSPSC 85814715, Introduction of oxazolidinones into female reproductive, percutaneous approach, is a Commodity code that describes a specific clinical procedure. Recent state and local procurement activity under this code shows no meaningful alignment with the nominal scope—the opportunities tagged with this code span virtual urgent care, occupational health services, psychology evaluations, behavioral health programming, inmate healthcare, and wellness administration. This mismatch signals that the code sits outside active state and local procurement focus or is being applied inconsistently by issuing bodies.

The code sees no identifiable recent activity grounded in the procedure it nominally describes. Among the opportunities posted in the source block, none address oxazolidinones, female reproductive healthcare delivery, or percutaneous pharmaceutical administration at scale. State and local procurement across the current dataset emphasizes occupational health, mental health and substance-use disorder treatment, emergency medical services, and institutional healthcare operations—service lines with substantially different clinical and operational profiles than the commodity's abstract name suggests. Without evidence of active solicitations materially aligned to this code's scope, pursuit should be deferred pending clarity on how issuing bodies are actually deploying it or whether it represents a data-categorization error in the broader taxonomy.